logo
ResearchBunny Logo
Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer's disease mouse model

Medicine and Health

Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer's disease mouse model

X. Cen, Y. Chen, et al.

This groundbreaking study reveals the therapeutic potential of UMI-77, a drug that activates neuronal mitophagy, targeting MCL-1 as a receptor. Conducted by Xufeng Cen and colleagues, it shows promise for reversing Alzheimer’s disease symptoms through potent mitophagy activation. A game-changer in Alzheimer's treatment!

00:00
00:00
Playback language: English
Abstract
This study investigates the therapeutic potential of inducing neuronal mitophagy for Alzheimer's disease. A screen of FDA-approved drugs identified UMI-77, a BH3-mimetic targeting MCL-1, as a potent mitophagy activator at sub-lethal doses. Mechanistic studies revealed MCL-1 as a mitophagy receptor directly binding to LC3A. In vivo studies using an APP/PS1 mouse model demonstrated that UMI-77 effectively reversed molecular and behavioral disease phenotypes by inducing mitophagy. These findings highlight MCL-1 as a potential drug target for Alzheimer's disease treatment.
Publisher
Nature Communications
Published On
Nov 12, 2020
Authors
Xufeng Cen, Yanying Chen, Xiaoyan Xu, Ronghai Wu, Fusheng He, Qingwei Zhao, Qiming Sun, Cong Yi, Jie Wu, Ayaz Najafov, Hongguang Xia
Tags
Alzheimer's disease
mitophagy
MCL-1
UMI-77
FDA-approved drugs
neurodegeneration
therapeutic potential
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny